GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cuorips Inc (TSE:4894) » Definitions » Cash Flow from Others

Cuorips (TSE:4894) Cash Flow from Others : 円0.00 Mil (TTM As of Sep. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Cuorips Cash Flow from Others?

Cuorips's cash flow from others for the three months ended in Sep. 2024 was 円0.00 Mil. Its cash flow from others for the trailing twelve months (TTM) ended in Sep. 2024 was 円0.00 Mil.


Cuorips Cash Flow from Others Historical Data

The historical data trend for Cuorips's Cash Flow from Others can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cuorips Cash Flow from Others Chart

Cuorips Annual Data
Trend Mar21 Mar22 Mar23 Mar24
Cash Flow from Others
-4.29 2.06 -8.99 36.13

Cuorips Quarterly Data
Mar21 Mar22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Sep24
Cash Flow from Others Get a 7-Day Free Trial Premium Member Only - - - - -

Cuorips Cash Flow from Others Calculation

Cash Flow from Others for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円0.00 Mil.

Cuorips Cash Flow from Others Related Terms

Thank you for viewing the detailed overview of Cuorips's Cash Flow from Others provided by GuruFocus.com. Please click on the following links to see related term pages.


Cuorips Business Description

Traded in Other Exchanges
N/A
Address
3-11-5 Nihonbashi-Honcho, 507, Nihonbashi Life Science Building 2, Chuo-ku, Tokyo, JPN, 103-0023
Cuorips Inc is engaged in the Research, development, manufacturing, and sales of Cellular and Tissue-based Products and Cell processing products. The company is also engaged in Contract development and manufacturing services and consulting services of Cellular and Tissue-based Products and Cell processing product.

Cuorips Headlines

No Headlines